BINEX Co., Ltd. (KOSDAQ:053030)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,270
+60 (0.39%)
Dec 10, 2025, 3:30 PM KST
2.76%
Market Cap484.40B
Revenue (ttm)165.64B
Net Income (ttm)-7.70B
Shares Out31.85M
EPS (ttm)-242.14
PE Ration/a
Forward PE35.11
Dividendn/a
Ex-Dividend Daten/a
Volume181,666
Average Volume193,912
Open15,300
Previous Close15,210
Day's Range15,060 - 15,370
52-Week Range12,800 - 23,250
Beta0.65
RSI56.85
Earnings DateNov 14, 2025

About BINEX

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. The company engages in cell line and process development, and analytical method production development. It is also involved in cell cultivation and microbial fermentation modalities process production. In addition, the company offers chemical pharmaceutical products. BINEX Co., Ltd. was founded in 1957 and is headquartered in Busan, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1957
Employees 626
Stock Exchange KOSDAQ
Ticker Symbol 053030
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.